Angeles Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Angeles Wealth Management's LLY Position: Q1 2026 in Review
Angeles Wealth Management increased its Eli Lilly (LLY) stake by 11% in Q1 2026, buying an estimated $742K and bringing the position to 7,458 shares worth $6.86M. The position accounts for 0.37% of the portfolio, ranked #35.
Angeles Wealth Management first reported a position in LLY in Q1 2022 and has held it in 17 quarters since. The position peaked at $7.23M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Angeles Wealth Management held 7,458 shares of Eli Lilly worth $6.86M as of Q1 2026.
- Angeles Wealth Management bought 732 Eli Lilly shares in Q1 2026, an estimated $742K.
- Eli Lilly made up 0.37% of Angeles Wealth Management's portfolio in Q1 2026, its #35 holding.
- Angeles Wealth Management first reported a position in Eli Lilly in Q1 2022 and has held it in 17 quarters since.
- Angeles Wealth Management's Eli Lilly position peaked at $7.23M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Angeles Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.